Samin Darou Iranian Company (Joint Stock) was registered in December of 2014 and after equipping the factory with facilities and equipment and creating the necessary spaces for the production of Active Pharmaceutical Ingredients in accordance with GMP principles, it was put into operation in October of 2018.
Read MoreThe production of active pharmaceutical ingredients (APIs) is carried out through various methods worldwide, and with the advancement of technology...
Read More1. Humira (adalimumab) – produced by AbbVie – used to treat inflammatory joint diseases such as rheumatoid arthritis and other...
Read More